KREX Cytokine Protein Array
The KREX™ Cytokine protein array allows for simultaneous screening of autoantibodies to over 300 autoantigens comprising clinically significant protein classes such as cytokines, interleukins and other immunomodulatory proteins.
Leveraging on the patented Sengenics KREX™ functional proteomics technology ensures that all proteins on the KREX™ Cytokine protein array are full-length, correctly folded and functional with both conformational and non-conformational epitopes preserved.
- Distinguish individuals at elevated risk of developing ARDS or other severe complications of COVID-19 disease and may correspond to underlying aetiologies.
- Large-scale autoantibody profiling (aAb-p) of patients who have succumbed to COVID-19 and those who have recovered.
- Identification of disease complication sub-types for high-risk patients.
© 2008 – 2020 Sengenics All rights reserved | Sengenics Corporation Pte Ltd. Registered in Singapore no. 201734100D | Sengenics UK Ltd. Registered in England and Wales No 11016361